Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

OTC Application

4 Dec 2025 10:56

RNS Number : 2955K
Valereum PLC
04 December 2025
 

04/12/25

Valereum Plc

("Valereum", "VLRM" or the "Company")

Application to Cross-trade on the OTCQB Market

Valereum Plc (AQSE: VLRM) is pleased to announce that it has re-applied to the OTC Markets Group for its Ordinary Shares to be cross traded publicly on the OTCQB Market in the United States (the "Cross-trade"). Subject to the approval of OTC Markets Group and the satisfaction of customary conditions.

A successful Cross-trade on to the OTCQB Market will enable Valereum's shares to be traded in US dollars through a wide range of US brokers, providing North American investors with easier access. This increased visibility and accessibility is an integral component of Valereum's broader US capital-markets strategy, which includes the previously announced intention to progress towards a potential listing on either NASDAQ or the New York Stock Exchange. Strengthening the Company's presence within the United States is an important step in enhancing market reach, broadening the shareholder base, and supporting long-term liquidity.

The application follows the completion of Valereum's divestment of the majority of its stake in London BTC Company Limited. This strategic divestment removes a regulatory constraint that had previously prevented the Company from qualifying for an OTCQB Cross-trade under the Investment Company Act of 1940. Clearing this barrier facilitates access to a broader set of international capital pools.

The Board views the submission of the OTCQB application as further evidence of the momentum behind Valereum's strategic repositioning. Alongside the establishment of the Valereum QGP-SP vehicle and the continued advancement of the planned USD $200m Royalty & Streaming financing, the move towards the OTCQB Market reflects the Company's vision for long-term growth.

The Company intends to update the market as the Cross-trade application progresses and on any material developments related to its US capital-markets strategy.

For further information, please contact:

Valereum Plc

Karl Moss

 

Tel: +44 7938 767319 

Investor Hub

Fortified Securities

Guy Wheatley

 

Tel: +44 203 4117773

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge 

 

 

Tel: +44 20 3855 5551

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

Please visit the Company's website at www.vlrm.com

 

For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub

 

IMPORTANT NOTICES

 

The Company holds cryptocurrencies or crypto assets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the UK (the Financial Conduct Authority or FCA) considers investment in cryptocurrencies to be high risk. At the outset, it is important to note that an investment in the Company is not an investment in cryptocurrencies, either directly or by proxy and shareholders will have no direct access to the Company's holdings. However, the Board of Directors consider cryptocurrencies to be an appropriate store of value and potential growth and therefore appropriate for the Company. Accordingly, the Company is and intends to continue to be materially exposed to cryptocurrencies.

 

The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the UK. As with most other investments, the value of cryptocurrencies can go down as well as up, and therefore the value of the Company's cryptocurrencies holdings can fluctuate. The Company may not be able to realise its cryptocurrencies holdings for the same as it paid to acquire them or even for the value the Company currently ascribes to its cryptocurrencies positions due to market movements. Neither the Company nor investors in the Company's shares are protected by the UK's Financial Ombudsman Service or the Financial Services Compensation Scheme.

 

Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and commingling of funds could cause unwanted delay; and (iv) crypto assets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGPAPUPAGUC
Date   Source Headline
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares
18th Aug 20257:00 amRNS-RIndirect Investee Update
14th Aug 20257:00 amRNSResult of WRAP Retail Offer
11th Aug 20254:30 pmRNSWRAP Retail Offer for up to £100,000
11th Aug 20257:00 amRNSStrategic Investment in Metrikus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.